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Understanding how hosts minimize the cost of emerging infections has fundamental implications for epidemiological dynamics
and the evolution of pathogen virulence. Despite this, few experimental studies in natural populations have tested whether, in
response to disease emergence, hosts evolve resistance, which reduces pathogen load through immune activation, or tolerance,
which limits somatic damages without decreasing pathogen load. Further, none has done so accounting for significant natural
variation in pathogen virulence, despite known effects on host responses to infection. Here, we investigate whether eastern
North American house finches (Haemorhous mexicanus) have evolved resistance and/or tolerance to their emerging bacterial
pathogen, Mycoplasma gallisepticum. To do so, we inoculated finches from disease-exposed and disease-unexposed populations
with 55 distinct isolates of varying virulence. First, although peak pathogen loads, which occurred approximately eight days
postinoculation, did not differ between experimentally inoculated finches from disease-exposed versus unexposed population,
pathogen loads subsequently decreased faster and to a greater extent in finches from exposed populations. These results suggest
that finches from exposed populations are able to clear the infection through adaptive immune processes. Second, however, finches
from exposed populations also displayed lower symptom severity for a given pathogen load, suggesting that a damage-limitation
mechanism, or tolerance, has accompanied the evolution of immune clearance. Our results highlight that resistance and tolerance
should be seen as complementary, not alternative, defense strategies: the evolution of resistance benefits from the concomitant
evolution of tolerance mechanisms that protect against the damage of immune activation, whereas the evolution of tolerance
without resistance will risk runaway selection on pathogen virulence.
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Impact Summary
Emerging infections can have devastating impacts on
their hosts, yet how hosts naturally evolve to deal with
novels infections remains poorly understood. In partic-
ular, it remains unclear whether hosts evolve to become
more resistant by mounting an immune response that
will clear the infection, or whether they evolve to be-
come more tolerant by lessening the symptoms of the
infection. Understanding how hosts evolve to respond
to infection is made all the more challenging by the fact
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that, for a given disease, there is natural variation in
the level of aggression (i.e., virulence) of the infectious
agents in circulation. Because more virulent pathogen
variants are likely to give rise to stronger host responses,
variation in virulence will impact our measurements of
host responses to infection. As a result, if we want to un-
derstand how hosts evolve to deal with novel infections,
we need to measure these responses against a range of
pathogen variants that differ in their level of virulence.
In this article, we take advantage of a naturally emerg-
ing infection in a wild North American songbird (house
finches) to test whether hosts evolve resistance or tol-
erance. We experimentally infect house finches with 55
pathogen variants of differing virulence, and compare
the response of finches from disease-exposed popula-
tions that are known to have evolved in response to in-
fection with that of finches from disease-unexposed pop-
ulations, which remain susceptible to the infection. We
show that, relative to finches from disease-unexposed
populations, finches from disease-exposed populations
have evolved to be able to clear the infection through
an immune response, and to limit the damages due to
the infection. Thus, resistance and tolerance should be
seen as complementary, rather than opposing, defense
strategies.
Hosts can alleviate the costs of infection by evolving two
distinct—although not necessarily mutually exclusive—strategies
(Kover and Schaal 2002; Schneider and Ayres 2008). They can
evolve resistance, which serves to reduce the establishment of
infectious pathogens and/or to clear pathogens following estab-
lishment (Boots and Bowers 2004; Janeway 2005), and they can
evolve tolerance. The latter serves to mitigate somatic damage
caused by the infection without reducing pathogen load (Ra˚berg
et al. 2009; Medzhitov et al. 2012; Ra˚berg 2014). Whether and
when hosts evolve resistance, tolerance, or both in response to
emerging pathogens have far-reaching consequences for predict-
ing virulence evolution and epidemiological dynamics (Miller
et al. 2006), as well as for the design of novel pharmacological
treatments (Vilaplana et al. 2013; Soares et al. 2017). Despite this,
few experiments have been performed to investigate the relative
importance of resistance versus tolerance in evolved responses to
naturally emerging pathogens.
Hypotheses based on the evolution of resistance versus toler-
ance make contrasting predictions. First, if resistance has evolved,
hosts will be better at clearing the infection and so show reduced
pathogen load during an infection relative to nonevolved hosts
(Miller et al. 2005, 2006; Ra˚berg et al. 2007). Second, if toler-
ance has evolved, hosts will be better able to mitigate the impact
of an increasing pathogen load. Under the widely used “range
tolerance” concept (Little et al. 2010), this would be detected
as a shallower negative regression of fitness on pathogen load
(Simms 2000). Alternatively, assuming that loss of fitness can be
directly attributed to clinical symptom severity, we would pre-
dict a weaker positive regression of symptoms severity (rather
than fitness) on pathogen load (Ra˚berg et al. 2007; see Box 1).
Given these predictions, it is important to reiterate that damage-
limitation mechanisms could evolve in conjunction with resis-
tance (e.g., by limiting immunity or initiating repair) (Restif and
Koella 2004; Howick and Lazzaro 2017). Thus, resistance and
tolerance mechanisms need not be mutually exclusive, and evi-
dence for the evolution of one is not necessarily evidence against
evolution of the other.
There have been few experimental tests of the predictions
for the evolution of resistance and tolerance in response to nat-
urally emerging pathogens, and the handful of studies to date
have yielded rather mixed conclusions. For example, strong ev-
idence for the evolution of resistance comes from observations
of the epidemic of myxoma virus in European rabbits (Orycto-
lagus cuniculus) in Australia (Kerr and Best 1998; Kerr et al.
2015). Following initially dramatic population declines, at seven
years post-outbreak, rabbits from disease-exposed populations
displayed mortality rates of only25% in response to experimen-
tal infection. In contrast, mortality rates of over 88% were found
in unexposed wild and domestic rabbits (Marshall and Fenner
1958; Marshall and Douglas 1961). Subsequent work confirmed
that reduced mortality was mediated by the evolution of innate
and cellular immune responses leading to significantly reduced
pathogen loads (Best and Kerr 2000). By contrast, the endemic
Hawaiian bird, Hawai‘i ‘Amakihi (Chlorodrepanis virens), was
suggested to have evolved tolerance to Plasmodium relictum, fol-
lowing the pathogen’s introduction to the archipelago around the
1930s (Van Riper et al. 1986). Experimentally infected ‘Amakihi
from high-altitude sites (where lower temperatures limit mosquito
numbers and malaria parasite development; Van Riper et al. 1986;
LaPointe et al. 2010), displayed significantly higher mortality and
weight loss than did individuals from low-altitude sites. Crucially,
however, there was no significant difference in pathogen load
(Atkinson et al. 2013).
Here, we test the role of resistance versus tolerance in evolu-
tionary responses of North American house finches (Haemorhous
mexicanus) to the emerging, conjunctivitis-causing bacterium My-
coplasma gallisepticum, following its jump from poultry in 1994
(Dhondt et al. 1998; Nolan et al. 1998). Several previous ex-
periments on this system have yielded apparently contradictory
conclusions. Bonneaud et al. (2011) concluded that resistance
had evolved from standing genetic variation within 12 years of
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BOX 1: Definitions, predictions, and implications of key terms
Typically, it is assumed that resistance and tolerance represent mutually exclusive evolutionary responses to emerging pathogens
(see “typical” predictions). However, there is no inherent reason why the two mechanisms cannot operate in tandem, which changes
the predictions for each (see “generalized” predictions). Note that predictions may be stated in terms of “fitness” rather than proxies
such as “clinical symptom severity.” The latter are more readily measured but carry implicit assumptions (e.g., that fitness declines
with increasing symptom severity). The choice of the response variable also has implications for the distinction between point and
range tolerance (see Fig. B1)
Definition Predictions Assumptions/Implications
Resistance: Resistant hosts are
better able to clear the
infection than nonresistant
hosts.
(Note that we consider here
resistance via immune
activity)
Typical: Resistant hosts display reduced pathogen
load relative to nonresistant hosts, which results in
reduced clinical symptoms but not in lower
symptom severity for an equivalent pathogen load
Generalised: Resistant hosts display reduced
pathogen load relative to nonresistant hosts, which
results in reduced clinical symptoms
Resistance and tolerance are mutually exclusive evolutionary
strategies
Resistance and tolerance can cooccur within the same evolutionary
response
Tolerance: Tolerant hosts are
better able to mitigate the
cost of infection than
nontolerant hosts.
Typical: Tolerant hosts display reduced symptom
severity relative to nontolerant hosts, but carry
equivalent (i.e., not significantly different)
pathogen load
Resistance and tolerance are mutually exclusive evolutionary
strategies
Generalised: Tolerant hosts display reduced symptom
severity conditional on pathogen load (which
may/may not be equivalent to nontolerant hosts).
Tolerance and resistance can cooccur within the same evolutionary
response
Range tolerance: Tolerant hosts
display reduced rate of
symptom worsening as
pathogen load increases than
nontolerant hosts.
The slope of the regression between clinical
symptoms and pathogen load is reduced for
tolerant hosts relative to nontolerant ones. Usually
estimated from symptom severity observed across a
range of nonzero pathogen loads.
If the measure of clinical symptom severity is assumed to equal 0 in
the absence of infection (i.e., pathogen load = 0), range and point
approaches to characterizing tolerance are equivalent (Fig. B1). If
this condition cannot be assumed biologically (e.g., because
symptoms are nonspecific) and/or is not imposed analytically,
empirical conclusions about tolerance may appear to differ
depending on whether a slope or point approach is taken (see
Fig. B1 legend).
Point tolerance: Tolerant hosts
display lower clinical
symptoms severity for a
given pathogen load.
Tolerant hosts display reduced clinical symptoms for
a given pathogen load relative to non-tolerant hosts.
Usually estimated from a symptom severity at a
single nonzero pathogen load.
Note that if fitness rather than symptom severity is used, point
tolerance approaches carry an implicit assumption of equal
y-intercepts (i.e., fitness in the absence of infection) that is unlikely
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Figure B1. Schematic figure of the regression of symptoms severity on pathogen load for two host genotypes. (A) Host genotypes
differing in tolerance, with the gold genotype being more tolerant to infection (i.e., symptoms severity increases more slowly with
increasing pathogen load). If we assume that symptoms severity is equal to 0 in the absence of infection (i.e., pathogen load = 0),
then any evidence of point tolerance (dots) will be equivalent to a difference in range tolerance (i.e., slopes). (B) and (C) For point
tolerance to be distinct from range tolerance, regression slopes of symptoms on pathogen load need to have intercepts that can differ
from 0. Hypothetically, host genotypes could then differ either (B) in range tolerance (i.e., slopes), but not in point tolerance (gray
dot), or (C) in point tolerance (dots), but not in range tolerance. It is difficult to imagine that infection-specific symptom severity is >0
in the absence of infection. Nonspecific indicator of health, on the other hand, could vary among uninfected individuals (as of course
could fitness). Nevertheless, if the severity of specific symptoms is used, we suggest that evidence of point but not range tolerance
(or vice versa) is an artefact of the sampling regime.
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outbreak: finches from disease-exposed populations displayed re-
duced pathogen load following infection with a virulent, contem-
porary 2007 isolate. By contrast, Adelman et al. (2013) concluded
that tolerance had evolved: finches from disease-exposed popu-
lations in 2010 had similar pathogen load, but reduced symp-
toms (conjunctival swelling) relative to finches from unexposed
populations and following inoculation with a low-virulence bac-
terial isolate collected at epidemic outbreak (i.e., in 1994). Fur-
ther experiments are clearly needed to understand the relative
roles of resistance and tolerance in the response to this emerg-
ing pathogen. In addition, because previous support for tolerance
evolution arises in part from a lack of significant differences in
pathogen load (as would be predicted under resistance evolution;
Ra˚berg et al. 2009), here we use a greater number of host indi-
viduals and of pathogen isolates of varying levels of virulence to
reduce the possibility of type II error.
We conducted a large-scale infection experiment using 112
naı¨ve house finches from disease-exposed (N = 53) and unex-
posed (N = 59) populations, and 55 bacterial isolates collected
from the epidemic outbreak (1994) and during the subsequent
20 years (until 2015). After emergence near Washington D.C.
in 1994, M. gallisepticum spread throughout the entire eastern
U.S. range of house finches within three years, killing millions
of birds (Fischer et al. 1997; Dhondt et al. 1998). Although it
later spread through much of the native western range (between
2000 and 2010; Duckworth et al. 2003; Dhondt et al. 2006), some
populations remain unexposed to date (e.g., in Arizona; Staley
et al. 2018). We have shown previously that the virulence of M.
gallisepticum, defined as the amount of damage done to the house
finch host, has increased over the course of the epidemic (Bon-
neaud et al. 2018; Tardy et al. 2019). Furthermore, we have shown
that house finches from exposed populations display less severe
symptoms than those from unexposed populations (Bonneaud
et al. 2018). In this study, we test the key contrasting predictions
set out above to determine whether this host evolutionary response
is principally attributable to changes in resistance or tolerance.
First, if finches from exposed populations have evolved re-
sistance, we would expect them to display lower pathogen loads
during infection than birds from unexposed populations (i.e., pop-
ulations that have not evolved resistance). Specifically, because
resistance to M. gallisepticum is thought to be mediated through
the ability to mount a cell-mediated immune response (Bonneaud
et al. 2012b), given evolved resistance, finches from exposed
populations are expected to show reduced pathogen load from
approximately two weeks postinfection (i.e., the time required to
mount a pathogen-specific immune response). By contrast, if tol-
erance alone has evolved, we predict no differences in pathogen
load over the course of the month-long infection experiment be-
tween finches from the two populations. Further, we would expect
that the relationship between symptom severity and pathogen load
will be shallower in birds from exposed populations (range tol-
erance; Ra˚berg et al. 2007), although reduced symptoms for a
given pathogen load have also been given as evidence of (point)
tolerance (Graham et al. 2011) (see Box 1).
Methods
CAPTURE AND HOUSING
Wild hatch-year house finches from populations that have never
been exposed to M. gallisepticum (unexposed populations) were
captured in urban areas and in suburban parks (see Bonneaud
et al. 2018) in Arizona over a two-week period of the summer
2015. We trapped, weighed, and banded each bird with a num-
bered metal tag for individual identification (N = 171; 93 males
and 78 females). They were then immediately transported by car
to an aviary at Arizona State University, where they were housed
for the remainder of the experiment. On arrival, we sampled blood
from each bird by brachial venipuncture (60 µL of whole blood)
and also took a choanal swab. A lack of prior infection was con-
firmed for each bird by screening blood plasma samples for anti-
M. gallisepticum antibodies using a serum plate agglutination as-
say (Luttrell et al. 1996). Absence of current infection was verified
using the choanal swabs in PCR amplification of M. gallisepticum
DNA (Roberts et al. 2001a). No prior or current M. gallisepticum
infections were detected (as expected given no documented re-
ports of M. gallisepticum from this area of Arizona; Staley et al.
2018). They were then allowed to acclimate in the aviary for >1
month, with ad libitum food and water. During this time, although
none of the birds displayed any sign of infection with other dis-
eases, all were treated prophylactically for Trichomonas gallinae
with carnidazole (Spartrix, Janssen/Elanco) and Isospora spp with
sulfadimethoxine in the first 40 days of captivity.
During the same time period, we also caught hatch-year
house finches from populations known to have been exposed
to M. gallisepticum since the disease outbreak (i.e., currently
maximally 20 host generations; exposed populations). All eastern
house finch populations were exposed to M. gallisepticum within
three years of outbreak, meaning that there is little variation in
exposure duration among them (Dhondt et al. 1998). These were
captured from urban areas and suburban parks in Alabama (see
Bonneaud et al. 2018). Birds were similarly banded weighed, and
sampled for blood and choanal swabs (N = 131). They were then
immediately transported by car to aviaries at Auburn University,
where they were housed separately in the same conditions as in
the aviaries in Arizona and tested for prior and current infection
as described above. Birds positive for either test were released im-
mediately and not used for the study. In this way, we ensured that
individuals from exposed populations used in the study had not
themselves been previously infected with the pathogen. These re-
maining individuals (N = 53; 24 males and 29 females) underwent
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>30-day quarantine period with ad libitum food and water, and
during which they were treated prophylactically for Trichomonas
gallinae and Isospora infections (see above). They were then
transported in an air-conditioned vehicle to the aviary at Arizona
State University. Care was used to minimize travel time (<30 h),
movement, and stress to the birds; food and water was provided ad
libitum throughout the trip and the birds were regularly checked
for any signs of distress or injury.
Following arrival at Arizona State University, 112 birds (53
birds from the exposed populations and 59 birds from the un-
exposed populations) were haphazardly selected for use in the
present study (the remaining 112 individuals being used in an-
other experiment). They were then allowed to acclimate in the
aviary, with ad libitum food and water, for >1 month prior to
experimental inoculation.
EXPERIMENTAL INOCULATION
We haphazardly inoculated each of the birds with one of 55 M.
galliseptum isolates sampled over the course of the epidemic. We
elected to use a large number of isolates in this paired design
so that differences between exposed and unexposed host popu-
lations can be interpreted as averaged across any isolate-specific
effects. This study is thus designed to draw maximally general
inference on between-host population differences in response to
M. gallisepticum infection. It is not designed to fully characterize
differences among pathogen isolates, an aim that would be better
served by using fewer isolates replicated across multiple hosts per
population. Isolates were originally obtained from naturally in-
fected, wild-caught house finches by swabbing the conjunctiva of
a symptomatic bird and placing the swab in SP4 growth medium.
Isolates were collected over a 20-year period and obtained from
various urban and suburban sites in eight different States in the
eastern United States (mainly from Alabama; Bonneaud et al.
2018). Isolates were administered via 20 µL of culture containing
1 × 104 to 1 × 106 color changing units/mL of M. gallisepticum
in both eyes. To quantify conjunctival swelling, we photographed
the right and left eyes at 0, 6, 13, and 25 days postinoculation
(dpi) from a standardized distance. We then measured the average
area of the conjunctiva swelling across the two eyes and at each
day as: the area of the outer ring minus the area of the inner ring
at 6, 13, or 25 dpi—the area of the outer ring minus the area of the
inner ring at 0 dpi (see Staley et al. 2018). Measurements were
blind with respect to the isolate inoculated and the population of
origin of the bird. The experiment was stopped at 35 dpi and all
birds were euthanized. Protocols were approved by Institutional
Animal Care and Use Committees of Auburn University (proto-
col # PRN 2015–2721) and of Arizona State University (protocol
#15-1438R), and by Institutional Biological Use Authorizations
to Auburn University (# BUA 500).
PATHOGEN LOAD
Bacterial load was measured by quantitative amplification of
M. gallisepticum DNA from pooled conjunctival and tracheal
swabs obtained at 8, 14, 21, and 28 dpi. DNA was extracted
using a QIAGEN DNeasy R© Blood and Tissue Kit according
to the manufacturer’s standard protocol (Qiagen, Germany).
For each sample, we ran a multiplex quantitative PCR of the
M. gallisepticum-specific gene mgc2, which encodes a cytad-
hesin protein, and the house finch recombination-activation gene
rag1, using an Applied BiosystemsTM StepOnePlusTM Real-Time
PCR system (Applied Biosystems, USA) (Tardy et al. 2019).
Each reaction contained: 2 µL of sample genomic DNA tem-
plate, 1 µL each of 10 µM mgc110-F/R, and rag1-102-F/R
primers (total 4 µL), 0.5 µL each of 10 µM Mgc110-JOE
and Rag1-102-6FAM fluorescent hydrolysis probes (total 1 µL),
10 µL of 2× qPCRBIO Probe Mix HI-ROX (PCR BIOSYS-
TEMS) and 3 µL Nuclease-free water (Ambion R©, USA). Re-
actions were then run at 95°C for 3 min, followed by 45
cycles of 95°C for 1 s and 60°C for 20 s. Samples were
run in duplicate alongside serial dilutions of plasmid-based
standards (range of standards for mgc2: 1.6 × 108 – 1.6 ×
103 copies; range of standards for rag1: 8.0 × 107 – 8.0 ×
102 copies). Amplification data were exported to LinRegPCR
version 2017.1 for calculation of individual reaction efficien-
cies and quantification of low-amplification samples (Ruijter
et al. 2009; Tuomi et al. 2010); between run variation was
normalized using Factor qPCR version 2016.0 (Ruijter et al.
2015), with plasmid standard serial dilutions used for factor
correction.
STATISTICAL ANALYSES
All statistical analyses were conducted in R 3.3.2 (Team RC 2016)
using linear mixed effect models fitted in lme4 (Bates et al. 2015),
and figures were made using ggplot2 (Wickham 2009). We pre-
viously showed that the probability of developing conjunctivitis
following experimental inoculation did not differ between birds
from exposed versus unexposed populations, but the former sub-
sequently displayed less severe symptoms (Bonneaud et al. 2018).
To test the roles of resistance and tolerance in this host evolution-
ary response, we restricted our analyses only to individuals that
became symptomatic (N = 83) and further removed 3 individuals
that died during the course of the experiment due to incomplete
data. We thus analyzed data from 80 symptomatic individuals
(N = 34 birds from exposed populations each inoculated with
a distinct isolate and 46 birds from unexposed populations in-
oculated with 1 of 45 isolates (one isolate from 2007 was in-
oculated into two birds from unexposed populations)). When
fitted as response variables, pathogen load was transformed us-
ing natural logarithm, whereas peak conjunctival swelling was
square root transformed to ensure normal residuals. In total, we
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ran three different models. First, we investigated the effects of
year of pathogen sampling and whether finches were obtained
from disease-exposed or unexposed populations on peak pathogen
loads (ln transformed) using a mixed linear model, with pathogen
isolate fitted as a random intercept. Second, to test for evidence of
population differences in the rate of pathogen clearance, we ran a
mixed effects model with ln(pathogen load) as the response term,
host population (exposed vs. unexposed), dpi (as a continuous
covariate), and their interaction as explanatory terms. Bacterial
isolate identity was included as a random intercept. Bird iden-
tity was included as an additional random term to account for
repeated measures of loads over the course of the experiment.
Third, we also used a mixed model to test for population dif-
ferences in the association between pathogen load and clinical
symptoms severity. Here peak conjunctival swelling (square root
transformed) was the response term, with host population, peak
pathogen load (square root transformed), and their interactions as
fixed effects. Bacterial isolate identity was again included as a ran-
dom intercept, but not individual bird identity (because each bird
was only represented once). We note that square root transforma-
tions can stabilize variance and, in this case, that risks removing
(or at least reducing) any signature of a population × pathogen
interaction on symptom severity. Because this interaction is key
to our hypothesis testing (i.e., we predict a steeper regression of
symptom severity on pathogen load in unexposed populations if
range tolerance has evolved), we reran this second analysis using
un-transformed conjunctival swelling data. As conclusions were
unaltered, we elected not present that analysis here (but see re-
sults in Supplementary Results and Fig. S1). In addition, we tested
whether evidence of point tolerance might be a manifestation of
range tolerance by rerunning the third model, but forcing the in-
tercept at 0, as would be expected under the assumption that with
no pathogen there are no symptoms.
Results
PATHOGEN LOAD
Over the course of the experiment, the median peak bacterial
load observed across all four measures of all individuals used
was 78 bacteria per host cell. There was marked variation around
this median (IQR of 42–154, total range of 1–522 bacteria per
host cell), arising in part from effects of bacterial isolate iden-
tity. Specifically, the mixed model analysis revealed that isolate
identity explained 19% of the variance in peak load. Further, as
expected, year of pathogen sampling showed a substantial pos-
itive effect on peak pathogen load, with later isolates achieving
higher peak load than early isolates (mixed GLM; linear estimate
± SE = 4.68 ± 1.15, χ2 = 4.99, df = 1, P = 0.025; quadratic
estimate ± SE = –2.53 ± 1.15, χ2 = 4.97, df = 1, P = 0.026).
Finally, however, peak loads were similar in birds from exposed
Figure 1. Changes in pathogen load over the experiment. We
show pathogen load (log-transformed) at 8, 14, 21, and 28 dpi for
birds from exposed and unexposed populations. Raw values are
shown as triangles (exposed) or circles (unexposed populations);
lines are predicted from the model (solid = exposed; dashed =
unexposed), with SEs represented by ribbons.
and unexposed populations on average (population effect (unex-
posed relative to exposed) ± SE = 0.004 ± 0.26, χ2 = 0.0003,
df = 1, P = 0.99). This latter result is not sufficient to distinguish
the roles of resistance and tolerance in the evolutionary response
to infection.
The absence of a population difference in peak load is not
incompatible with evolved resistance if pathogen loads are peak-
ing prior to the time when genetically resistant birds are able to
mount an effective immune response. Indeed, we found here that
bacterial loads were highest (on average) in birds from both pop-
ulations at 8 dpi and thereafter declined significantly on average
(mixed GLM; main dpi effect: estimate ± SE = –0.07 ± 0.009,
χ2 = 54.7, df = 1, P < 0.0001). However, there was a signifi-
cant population by dpi interaction (estimate ± SE = 0.07 ± 0.02,
χ2 = 13.9, df = 1, P< 0.0002), with birds from exposed popula-
tions clearing the pathogen approximately three times faster than
those from unexposed populations (Fig. 1). Differential clearing
rates are such that birds from exposed populations have a fourfold
lower bacterial load than birds from unexposed populations by
28 dpi. These findings support the hypothesis that genetic re-
sistance through acquired immunity has evolved in exposed
populations.
CONJUNCTIVAL SWELLING AS A FUNCTION OF
PATHOGEN LOAD
The key symptom of M. gallisepticum infection in house finches is
conjunctivitis, which, when severe, causes blindness and death in
the wild through starvation or predation (Roberts et al. 2001b;
Kollias et al. 2004; Adelman et al. 2017). Using the area of
conjunctival swelling to measure clinical symptom severity, we
found no obvious support for the hypothesis that tolerance, as
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Figure 2. Association between pathogen load and clinical symp-
tom severity. We show peak conjunctival swelling (square root-
transformed; in pixels) as a function of peak pathogen load (square
root-transformed) for birds from exposed and unexposed pop-
ulations. Raw values are shown as triangles (exposed) or cir-
cles (unexposed populations); lines are predicted from the model
(solid = exposed; dashed = unexposed), with SEs represented by
ribbons. Boxplot show the median and range peak conjunctival
swelling and peak pathogen load for each population. Birds from
exposed populations displayed significantly lower peak conjunc-
tival swelling than those from unexposed populations (estimate
± SE = –1.13 ± 0.54, χ2 = 4.36, df = 1, P = 0.037), but equivalent
peak pathogen load (see Results).
measured by the regression slope of peak symptom severity on
peak pathogen load, has evolved. Across all individuals used, the
mean measure of peak conjunctival swelling was 64.4 ± 34.0 pix-
els, and swelling increased with peak pathogen load as expected
(mixed GLM; pathogen load main effect: estimate ± SE = 0.21
± 0.052, χ2 = 15.30, df = 1, P< 0.0001). However, the slope of
this regression did not differ between exposed versus unexposed
populations (population × peak pathogen load interaction effect:
estimate ± SE = = –0.073 ± 0.10, χ2 = 0.52, df = 1, P = 0.47)
(Fig. 2). Nonetheless, birds from exposed populations did have
24% lower clinical symptom severity for any given pathogen load,
which is predicted under the point tolerance concept (population
main effect: estimate ± SE = 1.30 ± 0.50, χ2 = 6.88, df = 1, P =
0.009). We reran this analysis using the integral of pathogen load
rather than peak pathogen load as our predictor variable, but re-
sults were qualitatively unchanged (see Fig. S1). Thus, our results
suggest that mechanisms to limit immune damage have evolved
in tandem with resistance.
POINT VERSUS RANGE TOLERANCE
Although the evidence above is consistent with the concept of
point rather than range tolerance, the apparent distinction between
the two might be an artefact of whether asymptomatic hosts are
sampled (see Box 1). For example, because in our study all hosts
Figure 3. Association between pathogen load and clinical symp-
tom severity with intercept forced at 0. For birds from exposed
and unexposed populations, we show peak conjunctival swelling
(square root-transformed values) as a function of peak pathogen
load (square root-transformed). Raw values are shown as triangles
(exposed) or circles (unexposed populations); lines are predicted
from the model (solid = exposed; dashed = unexposed), with SEs
represented by ribbons.
were infected, the regression slopes of pathogen loads on con-
junctival swelling had intercepts in excess of zero. However, it
may be more reasonable to assume that with no pathogen, there
are no symptoms, and as a consequence the regression needs to
originate at 0 (see Fig. B1). Where this reasonable assumption
is made, any difference in points will derive from a difference in
slope. To test this possibility, we reran the model presented above,
but wherein we force the intercept to be 0. As expected, doing so
generates a significant difference in the slopes, with finches from
exposed populations showing reduced slope as expected under
range tolerance (mixed GLM; population × pathogen load inter-
action effect: estimate ± SE = –0.15 ± 0.06, χ2 = 4.9, df = 1,
P = 0.027: Fig. 3). These results suggest that there is no distinc-
tion between point and range tolerance, and any apparent evidence
of point tolerance is in fact evidence of range tolerance (Box 1
and Fig. B1).
Discussion
To test whether house finches from disease-exposed populations
have evolved resistance or tolerance to infection to the emerging
bacterial pathogen M. gallisepticum, we conducted an inoculation
experiment of house finches from disease-unexposed and exposed
populations using isolates collected over a 20-year period from
epidemic outbreak and differing in virulence. We found that birds
from exposed and unexposed populations had comparable peak
pathogen loads, which were maximal at 8 dpi in birds from both
populations. However, thereafter birds from previously exposed
populations cleared the pathogen more rapidly and to a greater
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extent during our experiment. That bacterial loads only started
to differ between exposed and unexposed finch populations af-
ter 14 dpi is consistent with our prior evidence that evolved
finches clear M. gallisepticum through cell-mediated immunity
(Bonneaud et al. 2012b). We interpret these patterns as evidence
that, in the exposed populations, hosts have evolved resistance in
response to the emerging pathogen M. gallisepticum.
In contrast to the evidence supporting the hypothesis of
evolved resistance, evidence for the evolution of tolerance in the
exposed finch population was more ambiguous. Notably, the gra-
dient of the regression of symptom severity on pathogen load
was comparable in birds from exposed and unexposed popula-
tions. In other words, because we did not observe the predicted
shallower regression slope for finches from exposed populations,
our results are ostensibly inconsistent with the hypothesis that
range tolerance to M. gallisepticum has evolved (sensu Little et al.
2010). Nonetheless, on average, birds from exposed populations
did exhibit lower clinical symptoms for a given pathogen load,
which suggests that a “tolerance” mechanism has evolved to limit
damage (i.e., symptom severity). Because we found a difference
in reaction norm intercept, but not slope, between unexposed
and exposed finch populations, strictly our results would more
consistent with the evolution of “point” than “range” tolerance
(see, e.g., Graham et al. 2011 and references therein for further
discussion).
That said, we suggest that the distinction between point and
range tolerance might be rather artificial, at least when symp-
tom severity rather than fitness is used on the y-axis, as we do
here (see Box 1). Most notably, if one makes the intuitive as-
sumption that potential hosts are asymptomatic prior to infection,
then any regression slope of symptom severity on pathogen loads
must intercept zero. And, where this is the case, any significant
point difference must result from a difference in slopes. Thus,
ostensible evidence of point tolerance might be a manifestation
of range tolerance, but wherein the range of pathogen loads fail
to include zero (we stress this is not necessarily true when fitness
used as variation in intercepts is expected even among uninfected
individuals). In support, when we forced the regression slopes
of symptom severity on pathogen load for the two host popula-
tions through zero, we found a significant difference between the
slopes: finches from exposed populations showed reduced slope
as expected under range tolerance.
Semantics over the definition and labels of tolerance notwith-
standing, what is clear is that any change in tolerance that has oc-
curred has been accompanied by a change in resistance. This novel
finding based on a large-scale inoculation experiment using >50
isolates collected throughout the epidemic helps to clarify previ-
ous ambiguity in this system. For instance, using a low-virulence
1994 isolate, Adelman et al. (2013) concluded a significant role
for tolerance, but not resistance, because inoculated finches from
exposed populations displayed comparable loads than those from
unexposed populations, but lower peak eye lesion scores. By con-
trast, Bonneaud et al. (2011) used a more virulent 2007 strain and
found population differences in pathogen load, consistent with
the evolution of resistance. We now know that there is substantial
among-isolate variation in peak pathogen load (this study), and
that differences in symptom severity between exposed and unex-
posed host populations are more apparent under infection with
late-epidemic bacterial isolates (Bonneaud et al. 2018). It there-
fore seems likely that studies performed on a restricted subset of
isolates (typically 1 isolate) will provide an incomplete picture of
host evolutionary responses to selection.
We would be surprised if our key finding that both resis-
tance and tolerance have evolved in response to the emerging
pathogen were not general. The overarching implication is that
although resistance and tolerance can be viewed as distinct host
defense strategies, this does not mean they must be either mech-
anistically independent or mutually exclusive. Indeed, immune
cells are increasingly recognized as playing a dual role in resis-
tance and damage-limitation processes in the broad sense (Wynn
and Vannella 2016; Kubes 2018). Clearly then there is value in
future studies addressing the role of evolved damage-limitation
mechanisms that curtail and resolve immune responses to pre-
vent autoimmunity, remove cellular debris and stimulate tissue
repair and regeneration (Wynn and Vannella 2016). The results of
our study highlight that future tests of resistance versus tolerance
evolution in response to naturally emerging pathogens require: (i)
inoculations with sufficient numbers of pathogen isolates taken
from varying time points of the host–pathogen interaction and
varying in virulence; and (ii) analyses of pathogen load over a
sufficient infection duration to encompass the consequences of
both innate and adaptive immune processes. Comparisons of the
results presented here with those published previously on the
house finch system (Adelman et al. 2013), including by ourselves
(Bonneaud et al. 2011), suggests that failure to do so is likely to
lead to reduced coherence regarding host responses to emerging
pathogens.
Not distinguishing between the contributions of resistance
and tolerance to evolved host defense will negatively impact the
ability to predict coevolutionary dynamics. For instance, although
resistance is implicated in antagonistic host–pathogen coevolution
(Gandon et al. 2003; Gandon et al. 2008), it is often noted that
the emergence of tolerance should benefit both parties, allowing
interactions to evolve toward commensalism (Roy and Kirchner
2000; Miller et al. 2006). In fact, we argue this latter prediction is
likely contingent on the assumption that virulence is a by-product
of pathogen replication rates rather than a direct target of selection
on pathogens (Anderson and May 1982; Ebert 1998; Mackinnon
and Read 1999a,b; Gandon et al. 2003; Miller et al. 2006). In this
case, tolerance alleviates the cost of virulence, thus allowing the
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pathogen to evolve high replication rates without causing damage
to coevolved (tolerant) hosts. However, in M. gallisepticum and
many other diseases (e.g., respiratory tract infections with aerosol
transmission), increased symptom severity may itself drive higher
transmission (Hornef et al. 2002). If so, the evolution of host
tolerance will actually impose selection for increased damage
(and so transmission) in coevolved (tolerant) hosts.
In the current context, M. gallisepticum requires virulence be-
cause transmission occurs through ocular fluid exudates (Dhondt
et al. 2007), and so depends on the bacterium causing a mis-
directed inflammatory response to disrupt the mucosal surface
of the conjunctiva and respiratory tract (Gaunson et al. 2000;
Lam and DaMassa 2000; Ganapathy and Bradbury 2003; Gaun-
son et al. 2006). Given that high virulence is broadly expected
to favor the evolution of host resistance, while low virulence
should favor tolerance (Restif and Koella 2003), it is intuitive that
obligately virulent pathogens should lead to the evolution of re-
sistance. In finches, resistance to M. gallisepticum via an effective
cell-mediated immune response does seem to have evolved, but
has likely been accompanied by the ability to resist the pathogen-
driven activation of an inflammatory response (Bonneaud et al.
2012a; Adelman et al. 2013). This interpretation is consistent with
our finding that the slopes of the relationships between pathogen
load and clinical symptoms severity (i.e., “range” tolerance) were
equivalent between finches from disease-exposed and unexposed
populations, but those from the latter displayed higher symptoms
overall.
In conclusion, we provide evidence that house finches
have evolved resistance following the infectious outbreak of the
bacterial pathogen, M. gallisepticum, with finches from disease-
exposed populations likely reducing pathogen load through
acquired immune processes (Bonneaud et al. 2011). Further,
however, we also found evidence to suggest that the ability
to tolerate infection and limit damage caused by the pathogen
has evolved in tandem with resistance. Thus, while tolerance
and resistance have been widely conceptualized as evolutionary
alternatives (Ra˚berg 2014), presumably because of their differing
implications for host–pathogen coevolution, from a host perspec-
tive they are better viewed as complementary strategies that are
likely to evolve together to fight infection and reduce damage.
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